Qnovia, Inc. announced its CEO is speaking publicly to FDA and NIH at the joint agency public meeting on Advancing Smoking Cessation today at FDA's White Oak Campus. Qnovia is a pharmaceutical company ...
Aim: To assess potential barriers to clinical integration of tailored smoking cessation treatment among African American and white smokers in the USA. Methods: A total of 392 smokers (203 white ...